{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:29:53Z","timestamp":1794446993394,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016003","name":"Mie University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Long-term outcomes in patients with lung metastases from sarcomas remain unreported. We retrospectively evaluated the clinical utility of lung radiofrequency ablation (RFA) in 52 patients with musculoskeletal sarcoma-derived lung metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>The study cohort included 29 men and 23 women with a mean age of 55\u00a0years at the time of the initial lung RFA, with a mean follow-up duration of 49.2\u00a0months. Complete treatment was defined as achieving a tumor-free status following the initial lung RFA. Cases failing to achieve this were classified as incomplete treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At the final follow-up, 14 patients remained alive, while 38 had died from this disease. Multivariate analysis confirmed that complete ablation and longer disease-free interval were significant prognostic factors. The median survival time for the 27 patients with complete treatment was 96.7\u00a0months, compared with 13.1\u00a0months for the 25 patients with incomplete treatment. The 3- and 5-year survival rates after the initial RFA in the 27 patients with complete treatment were 55.3% and 51.4%, respectively, whereas the corresponding rates for the incomplete treatment group were 16% and 10.7%. Of the 27 patients who achieved complete treatment, 4 had no new lung metastases, whereas 23 developed new lung metastases and\/or local relapse. Local tumor progression occurred in 30 of 266 lung tumors (11%); larger tumors showed a higher incidence of progression. No procedure-related mortality was reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Lung RFA can be a valuable option for treating lung metastases in patients with musculoskeletal sarcoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10147-026-02975-7","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T03:33:04Z","timestamp":1770175984000},"page":"640-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term clinical outcome of lung radiofrequency ablation in patients with musculoskeletal sarcoma"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1099-7436","authenticated-orcid":false,"given":"Tomoki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Hagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"2","key":"2975_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/jso.25504","volume":"120","author":"R Nevala","year":"2019","unstructured":"Nevala R, J\u00e4\u00e4maa S, Tukiainen E et al (2019) Long-term results of surgical resection of lung metastases from soft tissue sarcoma: a single center experience. J Surg Oncol 120(2):168\u2013175. https:\/\/doi.org\/10.1002\/jso.25504","journal-title":"J Surg Oncol"},{"key":"2975_CR2","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.2147\/CMAR.S333721","volume":"13","author":"T Nakamura","year":"2021","unstructured":"Nakamura T, Asanuma K, Takao M et al (2021) Clinical outcome in soft tissue sarcoma patients with lung metastasis who received metastasectomy and\/or radiofrequency ablation: Tokai musculoskeletal oncology consortium study. Cancer Manag Res 13:8473\u20138480. https:\/\/doi.org\/10.2147\/CMAR.S333721","journal-title":"Cancer Manag Res"},{"key":"2975_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/cncr.28111","volume":"104","author":"SE Leary","year":"2015","unstructured":"Leary SE, Wozniak AW, Billups CA et al (2015) Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children\u2019s Research Hospital experience. J Clin Oncol 104:194\u2013199. https:\/\/doi.org\/10.1002\/cncr.28111","journal-title":"J Clin Oncol"},{"issue":"3","key":"2975_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.athoracsur.2024.05.023","volume":"119","author":"M Eisenberg","year":"2025","unstructured":"Eisenberg M, Deboever N, Hofstetter WL et al (2025) Pulmonary surgical margins for metastatic osteosarcoma: is negative margin enough? Ann Thorac Surg 119(3):616\u2013624. https:\/\/doi.org\/10.1016\/j.athoracsur.2024.05.023","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"2975_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","volume":"113","author":"U Pastorino","year":"1997","unstructured":"Pastorino U, Buyse M, Friedel G et al (1997) Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 113(1):37\u201349. https:\/\/doi.org\/10.1016\/S0022-5223(97)70397-0","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"2975_CR6","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1245\/s10434-025-17450-2","volume":"32","author":"A Burkhard-Meier","year":"2025","unstructured":"Burkhard-Meier A, Grube M, Jurinovic V et al (2025) Does size outweigh number in predicting survival after pulmonary metastasectomy for soft tissue sarcoma? Insights from a retrospective multicenter study. Ann Surg Oncol 32(8):5948\u20135956. https:\/\/doi.org\/10.1245\/s10434-025-17450-2","journal-title":"Ann Surg Oncol"},{"issue":"suppl","key":"2975_CR7","doi-asserted-by":"publisher","first-page":"S457","DOI":"10.4103\/0973-1482.183207","volume":"14","author":"Y Li","year":"2018","unstructured":"Li Y, Zhang W, Li S et al (2018) Clinical efficiency of repeated pulmonary metastasectomy in sarcoma patients with recurrent pulmonary metastasis: a meta-analysis. J Cancer Res Ther 14(suppl):S457\u2013S462. https:\/\/doi.org\/10.4103\/0973-1482.183207","journal-title":"J Cancer Res Ther"},{"issue":"6","key":"2975_CR8","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.athoracsur.2017.07.024","volume":"104","author":"NP Chudgar","year":"2017","unstructured":"Chudgar NP, Brennan MF, Tan KS et al (2017) Is repeat pulmonary metastasectomy indicated for soft tissue sarcoma? Ann Thorac Surg 104(6):1837\u20131845. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.07.024","journal-title":"Ann Thorac Surg"},{"issue":"suppl 1","key":"2975_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3747\/co.27.5475","volume":"27","author":"A Smrke","year":"2020","unstructured":"Smrke A, Wang Y, Simmons C (2020) Update on systemic therapy for advanced soft-tissue sarcoma. Curr Oncol 27(suppl 1):25\u201333. https:\/\/doi.org\/10.3747\/co.27.5475","journal-title":"Curr Oncol"},{"key":"2975_CR10","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.2147\/DDDT.S275526","volume":"14","author":"T Nakamura","year":"2020","unstructured":"Nakamura T, Asanuma K, Hagi T et al (2020) Clinical outcome of systemic treatment for advanced soft tissue sarcoma: real-life perspective in Japan. Drug Des Devel Ther 14:4215\u20134220. https:\/\/doi.org\/10.2147\/DDDT.S275526","journal-title":"Drug Des Devel Ther"},{"issue":"10028","key":"2975_CR11","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/S0140-6736(15)01283-0","volume":"387","author":"P Sch\u00f6ffski","year":"2016","unstructured":"Sch\u00f6ffski P, Chawla S, Maki RG et al (2016) Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomized, open-label, multicenter, phase 3 trial. Lancet 387(10028):1629\u20131637. https:\/\/doi.org\/10.1016\/S0140-6736(15)01283-0","journal-title":"Lancet"},{"issue":"30","key":"2975_CR12","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1200\/JCO.2016.71.6605","volume":"35","author":"GD Demetri","year":"2017","unstructured":"Demetri GD, Sch\u00f6ffski P, Grignani G et al (2017) Activity of eribulin in patients with advanced liposarcoma demonstrated in a subgroup analysis from a randomized phase III study of eribulin versus dacarbazine. J Clin Oncol 35(30):3433\u20133439. https:\/\/doi.org\/10.1200\/JCO.2016.71.6605","journal-title":"J Clin Oncol"},{"issue":"2","key":"2975_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jjco\/hyw175","volume":"47","author":"A Kawai","year":"2017","unstructured":"Kawai A, Araki N, Naito Y et al (2017) Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma. Jpn J Clin Oncol 47(2):137\u2013144. https:\/\/doi.org\/10.1093\/jjco\/hyw175","journal-title":"Jpn J Clin Oncol"},{"issue":"14","key":"2975_CR14","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/cncr.28111","volume":"119","author":"SE Leary","year":"2013","unstructured":"Leary SE, Wozniak AW, Billups CA et al (2013) Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children\u2019s Research Hospital experience. Cancer 119(14):2645\u20132653. https:\/\/doi.org\/10.1002\/cncr.28111","journal-title":"Cancer"},{"issue":"1","key":"2975_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1186\/s12885-018-4872-x","volume":"18","author":"J Xu","year":"2018","unstructured":"Xu J, Guo W, Xie L (2018) Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma? BMC Cancer 18(1):987. https:\/\/doi.org\/10.1186\/s12885-018-4872-x","journal-title":"BMC Cancer"},{"issue":"1","key":"2975_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-024-00692-w","volume":"24","author":"H Huang","year":"2024","unstructured":"Huang H, Chen H, Zheng D et al (2024) Habitat-based radiomics analysis for evaluating immediate response in colorectal cancer lung metastases treated by radiofrequency ablation. Cancer Imaging 24(1):44. https:\/\/doi.org\/10.1186\/s40644-024-00692-w","journal-title":"Cancer Imaging"},{"key":"2975_CR17","doi-asserted-by":"publisher","DOI":"10.22575\/interventionalradiology.2024-0015","volume":"10","author":"Y Omori","year":"2025","unstructured":"Omori Y, Fujimori M, Yamanaka T et al (2025) Role of repeated radiofrequency ablation for patients with lung metastases of head and neck adenoid cystic carcinoma: long-term single-center study in 16 patients with 289 patients. Interv Radiol (Higashimatsuyama) 10:e20240015. https:\/\/doi.org\/10.22575\/interventionalradiology.2024-0015","journal-title":"Interv Radiol (Higashimatsuyama)"},{"issue":"3","key":"2975_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1148\/radiol.2020191272","volume":"294","author":"T Hasegawa","year":"2020","unstructured":"Hasegawa T, Takaki H, Kodama H et al (2020) Three-year survival rate after radiofrequency ablation for surgically resectable colorectal lung metastases: a prospective multicenter study. Radiology 294(3):686\u2013695. https:\/\/doi.org\/10.1148\/radiol.2020191272","journal-title":"Radiology"},{"issue":"9","key":"2975_CR19","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/1759-7714.12817","volume":"9","author":"BD Liu","year":"2018","unstructured":"Liu BD, Ye X, Fan WJ et al (2018) Expert consensus on image-guided radiofrequency ablation of pulmonary tumors: 2018 edition. Thorac Cancer 9(9):1194\u20131208. https:\/\/doi.org\/10.1111\/1759-7714.12817","journal-title":"Thorac Cancer"},{"issue":"2","key":"2975_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/COC.000000000013","volume":"37","author":"GMM Videtic","year":"2014","unstructured":"Videtic GMM, Chang JY, Chetty IJ et al (2014) ACR appropriateness criteria\u00ae early-stage non-small-cell lung cancer. Am J Clin Oncol 37(2):201\u2013207. https:\/\/doi.org\/10.1097\/COC.000000000013","journal-title":"Am J Clin Oncol"},{"issue":"16","key":"2975_CR21","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1002\/cncr.24420","volume":"115","author":"T Nakamura","year":"2009","unstructured":"Nakamura T, Matsumine A, Yamakado K et al (2009) Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected]. Cancer 115(16):3774\u20133781. https:\/\/doi.org\/10.1002\/cncr.24420","journal-title":"Cancer"},{"issue":"6","key":"2975_CR22","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2019.12.09","volume":"8","author":"H Kodama","year":"2019","unstructured":"Kodama H, Yamakado K, Taniguchi J et al (2019) Advances in percutaneous lung tumor therapy: 2019 update. Chin Clin Oncol 8(6):64. https:\/\/doi.org\/10.21037\/cco.2019.12.09","journal-title":"Chin Clin Oncol"},{"issue":"2","key":"2975_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien\u2013Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187\u2013196. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2","journal-title":"Ann Surg"},{"issue":"6","key":"2975_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10585-020-10056-w","volume":"37","author":"C Forster","year":"2020","unstructured":"Forster C, Ojanguren A, Perentes JY et al (2020) Is repeated pulmonary metastasectomy justified? Clin Exp Metastasis 37(6):675\u2013682. https:\/\/doi.org\/10.1007\/s10585-020-10056-w","journal-title":"Clin Exp Metastasis"},{"issue":"20","key":"2975_CR25","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.3748\/wjg.v20.i20.6133","volume":"20","author":"HK Kim","year":"2014","unstructured":"Kim HK, Cho JH, Lee HY et al (2014) Pulmonary metastasectomy for colorectal cancer: how many nodules, how many times? World J Gastroenterol 20(20):6133\u20136145. https:\/\/doi.org\/10.3748\/wjg.v20.i20.6133","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2975_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00270-013-0644-9","volume":"37","author":"C Koelblinger","year":"2014","unstructured":"Koelblinger C, Strauss S, Gillams A (2014) Outcome after radiofrequency ablation of sarcoma lung metastases. Cardiovasc Intervent Radiol 37(1):147\u2013153. https:\/\/doi.org\/10.1007\/s00270-013-0644-9","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"2975_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11604-016-0601-z","volume":"35","author":"T Sato","year":"2017","unstructured":"Sato T, Iguchi T, Hiraki T et al (2017) Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients. Jpn J Radiol 35(2):61\u201367. https:\/\/doi.org\/10.1007\/s11604-016-0601-z","journal-title":"Jpn J Radiol"},{"issue":"13","key":"2975_CR28","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1245\/s10434-011-1806-0","volume":"18","author":"J Palussi\u00e8re","year":"2011","unstructured":"Palussi\u00e8re J, Italiano A, Descat E et al (2011) Sarcoma lung metastases treated with percutaneous radiofrequency ablation: results from 29 patients. Ann Surg Oncol 18(13):3771\u20133777. https:\/\/doi.org\/10.1245\/s10434-011-1806-0","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2975_CR29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10147-013-0640-8","volume":"19","author":"K Yamakado","year":"2014","unstructured":"Yamakado K, Matsumine A, Nakamura T et al (2014) Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates. Int J Clin Oncol 19(5):955\u2013962. https:\/\/doi.org\/10.1007\/s10147-013-0640-8","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"2975_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11912-022-01244-w","volume":"24","author":"T Nakamura","year":"2022","unstructured":"Nakamura T, Sudo A (2022) Treatment strategy for elderly patients with soft tissue sarcoma. Curr Oncol Rep 24(5):563\u2013571. https:\/\/doi.org\/10.1007\/s11912-022-01244-w","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"2975_CR31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/annonc\/mdv037","volume":"26","author":"T de Ba\u00e8re","year":"2015","unstructured":"de Ba\u00e8re T, Aup\u00e9rin A, Deschamps F et al (2015) Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 26(5):987\u2013991. https:\/\/doi.org\/10.1093\/annonc\/mdv037","journal-title":"Ann Oncol"},{"issue":"2","key":"2975_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00270-010-9860-8","volume":"34","author":"T de Ba\u00e8re","year":"2011","unstructured":"de Ba\u00e8re T (2011) Lung tumor radiofrequency ablation: where do we stand? Cardiovasc Intervent Radiol 34(2):241\u2013251. https:\/\/doi.org\/10.1007\/s00270-010-9860-8","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"2975_CR33","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1245\/s10434-008-9848-7","volume":"15","author":"JC Zhu","year":"2008","unstructured":"Zhu JC, Yan TD, Morris DL (2008) A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol 15(6):1765\u20131774. https:\/\/doi.org\/10.1245\/s10434-008-9848-7","journal-title":"Ann Surg Oncol"},{"key":"2975_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2024.110396","volume":"119","author":"JGM Maluf","year":"2025","unstructured":"Maluf JGM, Araujo-Filho JAB, Martins GLP et al (2025) Complications related to radiofrequency ablation of lung tumors: CT findings and review. Clin Imaging 119:110396. https:\/\/doi.org\/10.1016\/j.clinimag.2024.110396","journal-title":"Clin Imaging"},{"issue":"6","key":"2975_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.diii.2022.03.004","volume":"103","author":"A Tual","year":"2022","unstructured":"Tual A, Revel MP, Canniff E et al (2022) Risk of pleural and diaphragmatic complications following percutaneous radiofrequency ablation of basal lung nodules. Diagn Interv Imaging 103(6):324\u2013326. https:\/\/doi.org\/10.1016\/j.diii.2022.03.004","journal-title":"Diagn Interv Imaging"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-02975-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-02975-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-02975-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:13:30Z","timestamp":1774415610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-02975-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2975"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-02975-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest regarding this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}